Journey Medical Official Logo

Investors»

Journey Medical Official Logo

Investors»

ROSACEA

Advancing Treatment Options for Rosacea

Severe Rosacea
Rosacea
Rosacea
Rosacea
Rosacea
Severe Rosacea

Rosacea is a chronic, relapsing inflammatory skin disease affecting an estimated 16 million Americans and as many as 415 million people worldwide. It primarily involves the central face and is characterized by recurring redness (flushing and persistent erythema), visible blood vessels (telangiectasia), and in many cases, acne-like inflammatory lesions (papules and pustules). While rosacea can affect anyone, it is most commonly seen in fair-skinned adults and is more frequently diagnosed in women, though men tend to experience more severe symptoms of the disease. Rosacea is generally classified into four subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular. Patients may experience features of more than one subtype over time, with symptoms that fluctuate between periods of flare and calm.1,2,3,4,5

The exact cause of rosacea is not fully understood. Environmental and lifestyle triggers, including sun exposure, temperature changes, stress, and certain foods or beverages, can provoke a response that drives the visible signs of the disease. Because no single mechanism fully explains the condition, and because its presentation varies so widely between patients, treatment is individualized to each person's specific symptoms, triggers, and quality-of-life needs.3,4
The burden of rosacea extends well beyond the skin. The condition is strongly associated with anxiety, embarrassment, and depression. Research has confirmed that rosacea carries a higher impact on daily life compared to acne, with more than half of patients reporting fatigue and difficulty sleeping as a result of their disease.6,7

POTENTIAL TREATMENTS

EMROSI® is a prescription medicine used to treat adults with pimples and bumps (inflammatory lesions) caused by a condition called rosacea. EMROSI should not be used for the treatment of infections. It is not known if EMROSI is safe and effective in children.

Important Safety Information

ZILXI® is a prescription medicine used on the skin (topical) to treat adults with pimples and bumps caused by a condition called rosacea.

ZILXI should not be used for the treatment of infections. It is not known if ZILXI is safe and effective in children. ZILXI is for use on the skin only (topical use). ZILXI is not for use in your mouth, eyes or vagina.

Important Safety Information
References:
  1. Rosacea Now Estimated to Affect at Least 16 Million Americans. (2010). National Rosacea Society.
    https://www.rosacea.org/rosacea-review/2010/winter/rosacea-now-estimated-to-affect-at-least-16-million-americans
  2. Study Estimates 415 Million People Affected by Rosacea Worldwide. (2018). National Rosacea Society.
    https://www.rosacea.org/rosacea-review/2018/summer/study-estimates-415-million-people-affected-by-rosacea-worldwide
  3. Rainer, B. M., Kang, S., & Chien, A. L. (2017). Rosacea: Epidemiology, pathogenesis, and treatment. Dermato-Endocrinology, 9(1).
    https://doi.org/10.1080/19381980.2017.1361574
  4. Chen, C., Wang, P., Zhang, L., Liu, X., Zhang, H., Cao, Y., Wang, X., & Zeng, Q. (2023). Exploring the Pathogenesis and Mechanism-Targeted Treatments of Rosacea: Previous Understanding and Updates. Biomedicines, 11(8), 2153.
    https://doi.org/10.3390/biomedicines11082153
  5. Men with Rosacea Face Different Symptoms. (2015, June 29). National Rosacea Society.
    https://www.rosacea.org/blog/2015/june/men-with-rosacea-face-different-symptoms
  6. Farshchian, M., & Daveluy, S. (n.d.). Rosacea. PubMed; StatPearls Publishing.
    https://www.ncbi.nlm.nih.gov/books/NBK557574/
  7. Saurat, J.-H., Halioua, B., Baissac, C., Perez Cullell, N., Hayoun, Y. B., Saint Aroman, M., Taieb, C., & Skayem, C. (2024). Epidemiology of acne and rosacea: A worldwide global study. Journal of the American Academy of Dermatology, 90(5), 1016–1018.
    https://doi.org/10.1016/j.jaad.2023.12.038
Journey Medical Official Logo
Linkedin
Company
About Us
Board of Directors
Leadership
CONDITIONS
Rosacea
Primary Axillary Hyperhidrosis
Severe Recalcitrant Nodular Acne
Acne
Fungal Skin Infections
Skin Wounds
OUR BRANDS​
Emrosi
Qbrexza
Accutane
Amzeeq
Zilxi
Luxamend
Exelderm
Targadox
Patient Savings Program
Contact
Contact Us
Partnering
Journey Medical Official Logo
Linkedin
COMPANY
CONDITIONS
OUR BRANDS
PATIENT EDUCATION
CAREERS
CONTACT

© 2026 Journey Medical Corporation. All rights reserved June 2026 JMC-M16-R02.

Back To Top

INDICATION

EMROSI is a prescription medicine used to treat adults with pimples and bumps (inflammatory lesions) caused by a condition called rosacea.

EMROSI should not be used for the treatment of infections. It is not known if EMROSI is safe and effective in children.

IMPORTANT SAFETY INFORMATION

  • Do not take EMROSI if you are allergic to any tetracycline medicines.
  • Before using EMROSI, tell your healthcare provider about all the other medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. EMROSI and other medicines may affect each other and cause serious side effects.
  • Do not use EMROSI if you are pregnant, may become pregnant or are nursing. If you become pregnant while using EMROSI, talk to your doctor. Tetracycline medicine when taken by mouth during pregnancy, infancy and/or childhood up to the age of 8 years may permanently discolor teeth (yellow-gray-brown) and may slow the growth of bones.
  • Protect your skin from the sun while using EMROSI. Avoid sunlight or artificial sunlight such as sunlamps or tanning beds. Stop using EMROSI if you get a sunburn.
  • When taken by mouth, minocycline may cause feelings of lightheadedness, dizziness or a spinning feeling. You should not drive or operate dangerous machinery if you have these symptoms.

EMROSI is an extended-release capsule that contains minocycline, a tetracycline medicine. Tetracyclines, when taken by mouth, may cause serious side effects, including: serious skin or allergic reactions which can cause skin redness, rash, hives, sores in your mouth, or your skin blisters and peels; swelling of your face, eyes, lips, tongue, or throat; trouble swallowing or breathing; blood in your urine; fever, yellowing of the skin or the whites of your eyes (jaundice), dark colored urine; pain on the right side of the stomach area (abdominal pain); chest pain or abnormal heartbeats; swelling in your legs, ankles, and feet; diarrhea which may be caused by an infection that can cause watery or bloody stools; loss of appetite; tiredness; unexplained bleeding or bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness. Call your doctor right away if these side effects occur.

The most common side effects of EMROSI include stomach upset or burning (dyspepsia) after eating or drinking. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Journey Medical Corporation at 1-855-531-1859.

Please see full Prescribing Information, including Patient Product Information.

 

IMPORTANT SAFETY INFORMATION

  • Do not use ZILXI if you are allergic to ZILXI or any tetracycline medicine. Stop using ZILXI right away and call your doctor if you get a rash or other allergic symptom.
  • Before using ZILXI, tell your doctor about all of your medical conditions and the medicines you take. Do not use ZILXI if you are pregnant, may become pregnant or are nursing. If you become pregnant while using ZILXI, talk to your doctor. Tetracycline medicine when taken by mouth during pregnancy, infancy and/or childhood up to the age of 8 years may permanently discolor teeth (yellow-gray-brown) and may slow the growth of bones.
  • ZILXI is flammable. Avoid fire, flames, and smoking when applying and right after you apply ZILXI.
  • Protect your skin from the sun while using ZILXI. Avoid sunlight or artificial sunlight such as sunlamps or tanning beds. Stop using ZILXI if you get a sunburn.
  • When taken by mouth, minocycline may cause feelings of lightheadedness, dizziness or spinning. You should not drive or operate dangerous machinery if you have these symptoms.

ZILXI is a topical foam that contains minocycline, a tetracycline medicine. It is not taken by mouth. However, tetracyclines, when taken by mouth (capsules or tablets), may cause serious side effects, including: diarrhea which may be caused by an infection and can cause watery or bloody stools; loss of appetite; tiredness; yellowing of your skin or eyes (jaundice); bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness; discoloration or darkening of your skin, scars, teeth, or gums. Call your doctor right away if these side effects occur.

The most common side effect of ZILXI is diarrhea.

These are not all of the possible side effects with ZILXI. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Patient Information.

INDICATION

ZILXI® (minocycline) topical foam, 1.5% is a prescription medicine used on the skin (topical) to treat adults with pimples and bumps caused by a condition called rosacea.

ZILXI should not be used for the treatment of infections. It is not known if ZILXI is safe and effective in children. ZILXI is for use on the skin only (topical use). ZILXI is not for use in your mouth, eyes or vagina.